Dr. Martens plc (DOCS)
LSE
Closed
Aug 25, 2026
Day's Range
78.9052 wk Range
59.15Overview - DOCS - Dr. Martens plc
Key Statistics
Valuation
Enterprise Value
995.71M
P/E (Trailing)
‪40.90‬
P/E (Forward)
‪13.21‬
PEG Ratio
‪13.21‬
Price / Sales (TTM)
‪1.02‬
Price / Book
‪216.40‬
EV / EBITDA
‪11.61‬
Profitability
Profit Margin
‪3.11%‬
Operating Margin
‪15.64%‬
Return on Assets
‪5.12%‬
Return on Equity
‪6.53%‬
Ownership
Shares Outstanding
956.61M
Float
498.73M
Held by Insiders
‪41.78%‬
Held by Institutions
‪41.46%‬
Price stats
Beta
‪0.26‬
50-Day Avg
‪76.28‬
200-Day Avg
‪71.52‬
Dividends
Payout Ratio
‪106.25%‬
Frequency
Semi-Annual
Analyst Consensus
6 analysts
Average price target
‪£ 100.17‬Shariah Compliance
Report Date: Feb 16, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - DOCS - Dr. Martens plc
Peers - DOCS - Dr. Martens plc
Peer Comparison
Compared with companies in Footwear & Accessories listed on LSE.
Profile Summary - DOCS - Dr. Martens plc
About
Dr. Martens plc is a British public limited company renowned for its iconic footwear and accessories brand. Originating from the first '1460' boot crafted on 1 April 1960 in Wollaston, England, the company has grown into one of the world's most recognized footwear brands, symbolizing individual self-expression for a…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
